Page last updated: 2024-10-31

neostigmine and Anxiety

neostigmine has been researched along with Anxiety in 2 studies

Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.

Anxiety: Feelings or emotions of dread, apprehension, and impending disaster but not disabling as with ANXIETY DISORDERS.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fogaça, MV1
Fedoce, AG1
Ferreira-Junior, NC1
Guimarães, FS1
Resstel, LB1
Lange, MJ1

Other Studies

2 other studies available for neostigmine and Anxiety

ArticleYear
Involvement of M1 and CB₁ receptors in the anxiogenic-like effects induced by neostigmine injected into the rat prelimbic medial prefrontal cortex.
    Psychopharmacology, 2016, Volume: 233, Issue:8

    Topics: Animals; Anxiety; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Injections, Intravent

2016
Cholinesterase inhibitors in myasthenia gravis.
    The Practitioner, 1966, Volume: 196, Issue:173

    Topics: Adult; Anxiety; Cholinesterase Inhibitors; Edrophonium; Female; Humans; Myasthenia Gravis; Neostigmi

1966